AI in Action E138: Carsten Ullrich, Director of AI at Centogene

,  | October 23 2020 | Mark Kelly

Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.

Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.

In the show, Carsten will discuss:

His 20 years of experience working in AI 

How Centogene are applying AI in rare diseases 

Challenges they need to overcome, such as data quality 

Improving diagnostics and leveraging this for new discoveries 

What makes Centogene a great place to work 

Their work with COVID-19 Testing 

The possibility of AI with Superhuman capabilities  

To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.

What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.

Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.

In the show, Carsten will discuss:

His 20 years of experience working in AI 

How Centogene are applying AI in rare diseases 

Challenges they need to overcome, such as data quality 

Improving diagnostics and leveraging this for new discoveries 

What makes Centogene a great place to work 

Their work with COVID-19 Testing 

The possibility of AI with Superhuman capabilities  

To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.

What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

related podcasts

AI in Action E543: James Milin, Co-Founder and Chief Executive Officer at Workhelix

Welcome to episode 543 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts…

Read More

ServiceNow Series E187: Michael Thunberg, Managing Director Nordics at Plat4mation

Welcome to episode 187 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being done…

Read More

AI in Action E542: Sumayah Rahman, Director of Data Science – Machine Learning and Infrastructure at Cedar

Welcome to episode 542 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts…

Read More